menu search

Jmp is bullish on this cancer stock "sees new way to treat cancer"

JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ: AURA) with a Market Outperform rating and a $26 risk-adjusted price ta...

July 19, 2022, 3:06 pm

Merck & astrazeneca partnered lynparza fails in late-stage colorectal cancer study

Merck & Co Inc (NYSE: MRK) will stop for futility the Phase 3 LYNK-003 trial of Lynparza with or without bevacizumab for unresectable or metastatic...

July 19, 2022, 1:15 pm

Patient death prompts macrogenics to close mid-stage head & cancer study

MacroGenics Inc (NASDAQ: MGNX) closed the Phase 2 study (CP-MGA271-06) of enoblituzumab in the first-line treatment of patients with recurrent or m...

July 11, 2022, 6:42 am

Exact sciences schedules second quarter 2022 earnings call

MADISON, Wis. , July 8, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer...

July 8, 2022, 6:00 am

Astrazeneca acquires blood cancer specialist teneotwo for up to us$1.2bn

AstraZeneca PLC (LSE:AZN) has struck a deal to swallow up a US-based owner of potential new drug cancer medicines for an initial U$S100mln (£82.6mln)...

July 5, 2022, 2:30 am

Mirati (mrtx) down 23% on mixed data from lung cancer study

Mirati (MRTX) posts positive data from a phase II study evaluating its lung cancer candidate adagrasib. However, the drug caused side-effects in a lar...

May 27, 2022, 3:49 pm

Cancer treatments may benefit from lessons of pandemic set-backs -astrazeneca executive

Although cancer screening and diagnosis was hit by the coronavirus pandemic, resulting advances in medi...

May 26, 2022, 1:07 pm

Veracyte, inc. (vcyt) ceo marc stapley on q1 2022 results - earning calls transcript

Veracyte, Inc. (NASDAQ:VCYT ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Marc Stapley – Chief Executive Officer Re...

May 3, 2022, 8:49 pm

Perimeter medical imaging ai to host conference call and webcast to discuss fourth quarter and year-end 2021 financial results and provide corporate update

TORONTO & DALLAS--(BUSINESS WIRE)--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medi...

May 3, 2022, 4:01 pm

Gamida cell shares jump on fda nod to cell therapy trial in blood cancer settings

The FDA has signed off and removed the clinical hold for a cryopreserved formulation of Gamida Cell Ltd's (NASDAQ: GMDA) GDA-201, an off-the-shelf...

April 26, 2022, 9:33 am

Aim immunotech shares jump on positive data from ampligen study in breast cancer setting

AIM ImmunoTech Inc (NYSE: AIM) has announced the presentation of positive data from a Phase 1 study of Ampligen in metastatic triple-negative breas...

April 11, 2022, 9:30 am

Clovis (clvs) up 24% on upbeat data from ovarian cancer study

Clovis Oncology's (CLVS) stock price rises after it reports favorable data from a late-stage study on Rubraca as the first-line maintenance treatment ...

April 4, 2022, 4:33 pm

Angle technology used in metastatic breast cancer research

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said its liquid biopsy system was central to research carried out by scientists attempting to understand why breast <...

April 1, 2022, 2:57 am

Volitionrx strikes exclusive $28m deal with heska corp to sell its nu.q vet cancer screening test

VolitionRx (NYSE-A:VNRX) Ltd has struck an exclusive $28 million deal with veterinary diagnostic firm Heska Corporation to license and sell the former...

March 29, 2022, 10:34 am

Astrazeneca's (azn) imfinzi misses goal in cervical cancer study

AstraZeneca's (AZN) blockbuster drug Imfinzi fails to achieve progression-free survival endpoint with statistical significance in cervical cancer pati...

March 25, 2022, 3:48 pm

Gilead's (gild) trodelvy late-line breast cancer study meets goal

While Gilead's (GILD) phase III study evaluating Trodelvy in late-line HR+/HER- breast cancer did achieve its primary endpoint, the lack of numerical ...

March 8, 2022, 5:18 pm

Alpine (alpn) down on fda partial clinical hold on cancer study

The FDA places a partial clinical hold on Alpine's (ALPN) NEON-2 study evaluating the combo of davoceticept plus Merck's Keytruda for treating advance...

March 8, 2022, 12:47 pm

Fda pushes tg therapeutics' ublituximab / ukoniq combo therapy applications in blood cancer settings

The FDA has extended the review period of TG Therapeutics Inc's (NASDAQ: TGTX) biologics license application and supplemental New Drug Application...

March 3, 2022, 11:27 am

Fda pushes tg therapeutics' ublituximab / ukoniq combo therapy applications in blood cancer settings

The FDA has extended the review period of TG Therapeutics Inc's (NASDAQ: TGTX) biologics license application and supplemental New Drug Application...

March 3, 2022, 11:27 am

Fda pushes tg therapeutics' ublituximab / ukoniq combo therapy applications in blood cancer settings

The FDA has extended the review period of TG Therapeutics Inc's (NASDAQ: TGTX) biologics license application and supplemental New Drug Application...

March 3, 2022, 11:27 am


Search within

Pages Search Results: